JPRN-UMIN000011455尚未招募未知
The involvement of mesalazine concentration in colonic mucosa of patients with ulcerative colitis under treatment with oral mesalazine - The involvement of mesalazine concentration in colonic mucosa of UC patients
Department of Gastroenterology and Hepatology, Kyoto University Hospital0 个研究点目标入组 50 人开始时间: 2013年9月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1:UC patients who were treated with pentasa enema or salazosulfapyridine suppository 2:Patients with rectal sparing 3:Patients who have a contraindication against mesalazine 4:Patients with severe renal failure 5:Patients with severe hepatic failure 6:Patients treated with prokinetic agents 7:Concomitant malignancies 8:Patients after gastrectomy 9:Under 20 year-old 10:no agreement for this study
研究者
相似试验
进行中（未招募）
不适用
Evaluation of the role of mesalazine in the treatment of diverticular disease of the colon and irritable colon syndrome: A randomised double blind placebo controlled clinical study - NDIrritable bowel Syndrome Diverticular disease of the colonMedDRA version: 9.1Level: LLTClassification code 10009993MedDRA version: 9.1Level: LLTClassification code 10023004EUCTR2008-004228-22-ITSOFAR SPA
进行中（未招募）
1 期
Mesacol: The effect of mesalazine on molecular pathways ofcell adhesion in ulcerative colitislcerative colitisMedDRA version: 14.1Level: LLTClassification code 10045366Term: Ulcerative colitis, unspecifiedSystem Organ Class: 100000004856EUCTR2012-002023-15-ATMedizinische Universität Wien, Universitätsklinik für Innere Medizin 3, Abteilung für Gastroenterologie und Hepatologie12
进行中（未招募）
1 期
Rectal mesalazine for FAP and MAPFamilial adenomatous polyposis(FAP) and MUTYH-associated polyposis (MAP)MedDRA version: 20.1 Level: PT Classification code 10056981 Term: Adenomatous polyposis coli System Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 20.1 Level: LLT Classification code 10059327 Term: Familial adenomatous polyposis System Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2018-003076-13-PTInstituto Português de Oncologia de Lisboa Francisco Gentil15
进行中（未招募）
1 期
Efficacy and mode of action of mesalazine in the treatment of diarrhoea-predominant irritable bowel syndrome (IBS-D). - Mesalazine for the treatment of IBS-DDiarrhoea-predominant irritable bowel syndromeMedDRA version: 14.0 Level: LLT Classification code 10060849 Term: Diarrhoea predominant irritable bowel syndrome System Organ Class: 10017947 - Gastrointestinal disordersEUCTR2010-018340-14-GBniversity of Nottingham136
进行中（未招募）
1 期
Mesapol: The effect of mesalazine on molecular pathways of celladhesion in patients with colon polypsColon polypsMedDRA version: 14.1Level: LLTClassification code 10066021Term: Acquired colon polyposisSystem Organ Class: 100000004856EUCTR2012-002024-32-ATMedizinische Universität Wien, Universitätsklinik für Innere Medizin 3, Abteilung für Gastroenterologie und Hepatologie12